BIOGEN INC. Tax Adjustments, Settlements, and Unusual Provisions
BIOGEN INC. (BIIB) had Tax Adjustments, Settlements, and Unusual Provisions of $5.00 million as of 2013-10-15, per its 10-K filed 2014-02-06.
Discontinued › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2014-02-06
- 2013-10-15: Tax Adjustments, Settlements, and Unusual Provisions $5.00M.
- 2011-08-31: Tax Adjustments, Settlements, and Unusual Provisions 1 month $7.00M.
- 2011-06-30: Tax Adjustments, Settlements, and Unusual Provisions 6 month $7.00M.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions | Tax Adjustments, Settlements, and Unusual Provisions 1 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month |
|---|---|---|---|
| 2013-10-15 | $5.00M 10-K · filed 2014-02-06 | ||
| 2011-08-31 | $7.00M 10-K · filed 2014-02-06 | ||
| 2011-06-30 | $7.00M 10-Q · filed 2011-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |